Date: 17-Oct-2019

Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing

Sanofi today celebrates the inauguration of its new digital manufacturing facility in Framingham, Massachusetts, marking one of the world's first digital facilities using intensified, continuous biologics production technology. The new facility features leading-edge technology that connects the production process with research and development, paving the way for improved commercialization of important new medicines for patients. This facility accelerates the recent transformation of Sanofi's Industrial Affairs organization to focus on biologics-based therapies, in line with the transformation of the company's R&D pipeline. The ramping up of bio-pharmaceutical production capacities is a key pillar to achieving Sanofi’s ambition to establish the gold standard in the bio-pharmaceutical industry.